Eleonora Teplinsky, MD, is the head of breast and gynecologic medical oncology and Valley-Mount Sinai Comprehensive Cancer Center in Paramus, New Jersey, as well as an ASCO breast cancer expert. She explained the most compelling research results on breast cancer presented at the 2026 American Society of Clinical Oncology Annual Meeting. Listen to the episode to hear Dr. Teplinsky explain: the importance of the OPTIMA study, as well as her caveats about the results the latest results from the ASCENT-04 study what progression-free survival 2 (PFS2) is and how it helps doctors decide which treatments should be given first what we do and don’t know about GLP-1 medicines and cancer

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related